Clinical Trial Update: Ketamine in Central Sensitization [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ketamine for central sensitization in endometriosis and chronic pelvic pain; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Pelvic Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Endometriosis, Chronic Pelvic Pain | Phase 4 | Status: NOT_YET_RECRUITING